EU Medicines Agency @EMA_News@respublicae.eu

RT by @EMA_News: How to understand infectious diseases' dynamics? How to track the pathogen evolution (such as e.x. #COVID19 variants?)

Listen to our brand new #ECDConAir podcast episode on #GenomicEpidemiology & the ECDC's #GenEpiBioTrain training here:
https://bit.ly/ECDConAir45

🐦🔗: https://nitter.cz/ECDC_EU/status/1745011714758705191#m

[2024-01-10 09:16 UTC]

RT by @EMA_News: 📢For all health stakeholders:
How to best exchange the latest ⚕️health-related news, increase visibility of health initiatives and build up strong networks?
Use the EU Health Policy Platform, #EUHPP, with over 6⃣0⃣0⃣0⃣ members.
👉More information: https://europa.eu/!chjPQH

🐦🔗: https://nitter.cz/EU_Health/status/1745011781725004245#m

[2024-01-10 09:16 UTC]

Many people struggling with depression need treatments with better efficacy, improved safety & more personalised profiles.
EMA encourages developers to share comments on the revised guideline on clinical investigation of
https://nitter.cz/search?q=%23antidepressants
by 31/03/2024.
➡️
https://www.cambridge.org/core/journals/european-psychiatry/article/new-ema-guideline-on-antidepressants-a-guide-for-researchers-and-drug-developers/37E69FCD252D9CE5510BEF035E5B253F

🐦🔗: https://nitter.cz/EMA_News/status/1745005736923443221#m

[2024-01-10 08:52 UTC]

Register now to participate online in the two-day workshop on
https://nitter.cz/search?q=%23PatientRegistries
📅12-13 February
👉Deadline: 12 January
🖥️
https://europa.eu/!PkxMYK

🐦🔗: https://nitter.cz/EMA_News/status/1744396042584703360#m

[2024-01-08 16:30 UTC]

RT by @EMA_News: #DYK that during the acute phase of the #COVID19 pandemic

🔸#HPV vaccine uptake ⬇️ 10-24% in some countries in the Region
🔸47% of reporting countries indicated some level of disruption in #screening

Action: Invest in health systems so that they are agile & resilient to shocks!

🐦🔗: https://nitter.cz/WHO_Europe/status/1743195905715511414#m

[2024-01-05 09:01 UTC]

RT by @EMA_News: Following annual review of our eligibility to remain as one of @EMA_News patients and consumers organisations, we are pleased to have received news that we continue to meet strict eligibility criteria and can continue to be involved in EMA activities
https://www.alzheimer-europe.org/news/alzheimer-europe-continues-comply-european-medicines-agencys-strict-eligibility-criteria-0

🐦🔗: https://nitter.cz/AlzheimerEurope/status/1743236246296572218#m

[2024-01-05 11:41 UTC]

RT by @EMA_News: #CervicalCancer is preventable.

In addition to #HPV vaccination, regular screening helps detect & protect women from cervical cancer.

🐦🔗: https://nitter.cz/WHO_Europe/status/1742098423954788592#m

[2024-01-02 08:20 UTC]

Together we can help prevent antibiotic
https://nitter.cz/search?q=%23shortages
this winter ❄ !
Learn more ⬇️
https://nitter.cz/search?q=%23medicines
https://nitter.cz/search?q=%23antibiotics
https://nitter.cz/search?q=%23publichealth

🐦🔗: https://nitter.cz/EMA_News/status/1739934149203349738#m

[2023-12-27 09:00 UTC]

Don’t forget to register for the EMA/
https://nitter.cz/EORTC
workshop on soft tissue and bone
https://nitter.cz/search?q=%23sarcoma
.
🗓️ Deadline 8 January:
https://www.ema.europa.eu/en/events/ema-and-eortc-multi-stakeholder-workshop-soft-tissue-and-bone-sarcoma
https://nitter.cz/search?q=%23cancer
https://nitter.cz/search?q=%23research
https://nitter.cz/search?q=%23medicines

🐦🔗: https://nitter.cz/EMA_News/status/1737735905933156746#m

[2023-12-21 07:25 UTC]

https://nitter.cz/search?q=%23JustPublished
: Midterm report on the European medicines agencies network strategy!
It offers a snapshot of key achievements and concrete deliverables by EU medicines regulators as they implement the strategy planned until 2025.
➡️
https://www.ema.europa.eu/en/news/midterm-report-2025-network-strategy-highlights-good-progress-during-critical-period-pandemic
https://nitter.cz/search?q=%23AMR
https://nitter.cz/search?q=%23COVID19

🐦🔗: https://nitter.cz/EMA_News/status/1737495400578224395#m

[2023-12-20 15:29 UTC]

Emer Cooke's end-of-year-message ‼️
Our Executive Director takes stock of what 2023 has meant for the work of the Agency.
Read the statement here 👇
https://www.ema.europa.eu/en/news/goodbye-2023-when-optimism-came-back

🐦🔗: https://nitter.cz/EMA_News/status/1737122216897081739#m

[2023-12-19 14:46 UTC]

📢Just published: workplan on
https://nitter.cz/search?q=%23ArtificialIntelligence
to 2028 will help medicines regulators in Europe embrace the opportunities of AI while managing the risks➡️
https://europa.eu/!9RjYwf

🐦🔗: https://nitter.cz/EMA_News/status/1736742921913676163#m

[2023-12-18 13:39 UTC]

Highlights of EMA’s December Management Board meeting are out! Read more about:
✔️ EMA’s 2024 work programme
✔️ Progress with the implementation of the veterinary
https://nitter.cz/search?q=%23medicines
and
https://nitter.cz/search?q=%23clinicaltrials
regulations.
https://www.ema.europa.eu/en/news/ema-management-board-highlights-december-2023-meeting

🐦🔗: https://nitter.cz/EMA_News/status/1735696331761504491#m

[2023-12-15 16:20 UTC]

📢 The
https://nitter.cz/search?q=%23CHMP
recommended 7 new medicines for approval, including:
☑️ 1st
https://nitter.cz/search?q=%23CRISPR
/Cas9 therapy to treat
https://nitter.cz/search?q=%23SickleCellDisease
&
https://nitter.cz/search?q=%23BetaThalassemia
☑️ a medicine for
https://nitter.cz/search?q=%23FriedreichsAtaxia
☑️ a medicine to treat
https://nitter.cz/search?q=%23Schistosomiasis
outside the 🇪🇺
https://europa.eu/!Qw3KK4

🐦🔗: https://nitter.cz/EMA_News/status/1735660079288840218#m

[2023-12-15 13:56 UTC]

R to @EMA_News: The 1st gene editing therapy to treat #SickleCellDisease & #BetaThalassemia recommended for approval by EMA's human medicines committee, is also the 1st medicine using a novel gene-editing technology (#CRISPR/Cas9) in the 🇪🇺.

➡️ https://www.ema.europa.eu/en/news/first-gene-editing-therapy-treat-beta-thalassemia-and-severe-sickle-cell-disease

#CHMP #PublicHealth

🐦🔗: https://nitter.cz/EMA_News/status/1735660082413592605#m

[2023-12-15 13:56 UTC]

RT by @EMA_News: With the #EUGlobalHealthStrategy we’re striving to regain lost ground on the Sustainable Development #GlobalGoals, including our shared ambition to reach universal health coverage.

It’s time for a new era for #globalhealth.

👉 https://europa.eu/!3Y6Hcr

🐦🔗: https://nitter.cz/EU_Health/status/1734595535636459748#m

[2023-12-12 15:26 UTC]

The agenda of EMA's human medicines committee
https://nitter.cz/search?q=%23CHMP
is now published. 💊💉
Find out what
https://nitter.cz/search?q=%23medicines
will be discussed this month:
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-11-14-december-2023_en.pdf
The committee highlights will be released on Friday.

🐦🔗: https://nitter.cz/EMA_News/status/1734202368609108366#m

[2023-12-11 13:23 UTC]

RT by @EMA_News: Don't miss the info session tomorrow on the new #EU4Health call for proposals for operating grants to #NGOs!
🗓️ 12 December
🕝 14.30 CET
Join the session online and learn more about the call: https://hadea.ec.europa.eu/events/info-session-eu4health-call-proposals-operating-grants-non-governmental-organisations-2023-12-12_en

🐦🔗: https://nitter.cz/EU_HaDEA/status/1734183595546214542#m

[2023-12-11 12:09 UTC]

We are thrilled to announce that our 🆕 website is live! 🎉
It features a fresh design, improved navigation, and aims to help you find the information you need more easily.
We look forward to connecting with you through our new website and beyond!
https://nitter.cz/search?q=%23EMAWebsite
https://nitter.cz/search?q=%23LaunchDay

🐦🔗: https://nitter.cz/EMA_News/status/1732055827823927380#m

[2023-12-05 15:14 UTC]

RT by @EMA_News: Exciting day as Marco Greco speaks at the Heads of Medicines Agencies/ @EMA_News Big Data Stakeholder Forum! #Bigdata holds promise for better, safer, and #personalised #treatments. Patients are at the heart of this journey, EPF welcomes the HMA/EMA's efforts in this area!

🐦🔗: https://nitter.cz/eupatientsforum/status/1731634827076551037#m

[2023-12-04 11:21 UTC]